Investment builds on Wellinks' strategic partnership with UMass Memorial Health and other commercial partners to accelerate growth and expand patient access to its predictive care model

此项投资依托 Wellinks 与 UMass Memorial Health 及其他商业合作伙伴的战略合作伙伴关系，旨在加速增长并扩大患者对其预测性护理模式的获取。

NEW HAVEN, Conn.

康涅狄格州纽黑文

,

，

Aug. 4, 2026

2026年8月4日

/PRNewswire/ -- Wellinks, a leader in cardiopulmonary care, today announced the first close of its Series B Funding, securing $10 million to fund commercial growth with participation from UMass Memorial Health and inside investors. The investment builds on Wellinks' multiyear relationship with UMass Memorial Health and other partners to accelerate the expansion of Wellinks' predictive care solution..

/美通社/ -- 心肺护理领域的领导者 Wellinks 今日宣布完成 B 轮融资的首次交割，获得 1,000 万美元资金，用于支持商业化增长。马萨诸塞大学纪念医疗中心（UMass Memorial Health）及现有投资者参与了本轮投资。此次投资建立在 Wellinks 与马萨诸塞大学纪念医疗中心及其他合作伙伴多年合作关系的基础之上，旨在加速扩展 Wellinks 的预测性护理解决方案。

Wellinks' FDA-cleared Spire Remote Patient Monitoring (RPM) System helps identify early physiologic changes associated with clinical deterioration, supporting earlier intervention and proactive management of chronic respiratory disease beyond traditional care settings.

Wellinks 的 FDA 认证 Spire 远程患者监测（RPM）系统有助于识别与临床恶化相关的早期生理变化，支持在超越传统护理场景的情况下进行早期干预和慢性呼吸道疾病的主动管理。

Wellinks and UMass Chan Medical School first collaboratively approached reducing acute care utilization in COPD patients through the Healthy at Home program.

Wellinks 与马萨诸塞大学陈医学院通过“健康在家”项目，首次合作致力于降低慢性阻塞性肺疾病患者的急性医疗资源使用。

The study

这项研究

found that Healthy at Home participants had more than 60% lower odds of 30-day hospital readmission, with trends toward fewer emergency department visits and shorter hospital stays than similar patients who did not participate. For more information, read

研究发现，“健康在家”参与者的30天医院再入院几率降低了60%以上，并且与未参与的相似患者相比，呈现出急诊就诊次数减少和住院时间缩短的趋势。更多信息，请阅读

'Healthy at Home study demonstrates feasibility, effectiveness of mobile care for COPD.'

“居家健康”研究证明了移动护理在慢性阻塞性肺疾病（COPD）管理中的可行性和有效性。

'Our continued collaboration with Wellinks reflects a shared commitment to advancing proactive, data-driven care,' said Dr. Eric Dickson, CEO at UMass Memorial Health. 'Together, we're generating real-world clinical evidence that supports better outcomes for patients and informs the future of cardiopulmonary care.'.

“我们与Wellinks的持续合作反映了我们在推进主动的、数据驱动的护理方面的共同承诺，”UMass Memorial Health的首席执行官Eric Dickson博士说。“我们共同努力，生成支持患者更好结局并指导心肺护理未来的真实世界临床证据。”

Wellinks will use the funding to:

Wellinks 将利用这笔资金：

Expand its commercial footprint

扩大其商业版图

and extend cardiopulmonary care to broader and more diverse patient populations, including rural and underserved communities.

并将心肺护理扩展至更广泛且更多样化的患者群体，包括农村地区和医疗资源不足社区的居民。

Advance its predictive capabilities

提升其预测能力

by leveraging a growing body of real-world clinical data to strengthen decision support and enhance the Wellinks care solution.

通过利用不断增长的现实世界临床数据，加强决策支持并优化 Wellinks 护理解决方案。

Expand into additional cardiopulmonary conditions

扩展至其他心肺疾病

, including congestive heart failure (CHF), by applying its technology and care model across a broader range of high-risk patient populations.

，包括充血性心力衰竭（CHF），通过将其技术和护理模式应用于更广泛的高危患者群体。

'This investment represents validation of the solution we've built and the outcomes it delivers,' said Jennifer Barretta, Chief Operating Officer and Interim CEO of Wellinks. 'Our approach aims to close care gaps for patients, including those at risk for poor adherence, leading to lower healthcare utilization and a reduced cost of care.'.

“这笔投资是对我们所构建的解决方案及其所带来成果的验证，”Wellinks 首席运营官兼临时首席执行官詹妮弗·巴雷塔表示。“我们的方法旨在缩小患者的护理差距，包括那些依从性较差风险较高的患者，从而降低医疗资源使用率和护理成本。”

About Wellinks

关于 Wellinks

Wellinks is redefining how respiratory care is delivered. Our solution combines the benefits of virtual chronic care disease management with the power of remote patient monitoring through our proprietary, FDA-cleared technology. Our Health Tags offer passive, continuous monitoring that predicts clinical deterioration up to one week before a patient feels the onset of symptoms.

Wellinks 正在重新定义呼吸护理的交付方式。我们的解决方案将虚拟慢性病管理的优势与我们专有的、获 FDA clearance 的远程患者监测技术相结合。我们的健康标签提供无感、持续监测，可在患者感到症状出现前长达一周预测临床恶化。

By pairing predictive insights with proactive clinical intervention, Wellinks demonstrates results in reducing acute care utilization, readmission rates, and total cost of care. We are closing care gaps and changing the paradigm in how this traditionally underserved population receives care..

通过将预测性洞察与主动临床干预相结合，Wellinks 在降低急性护理使用率、再入院率和总护理成本方面成效显著。我们正在弥补护理缺口，并改变这一传统上服务不足人群接受护理的模式。

For more information, visit

欲了解更多信息，请访问

www.wellinks.com

www.wellinks.com

and follow us on

并在关注我们

LinkedIn.

领英。

SOURCE Wellinks

来源 Wellinks

21

二十一

%

百分比

more press release views with

更多新闻稿浏览量，借助

Request a Demo

申请演示